Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice

European Journal of Pharmacology

Volumn 629, Issue 1-3, 2010, Pages 147-152

  Yuan, Xiao Ying ^a,b   Liu, Wei ^a,b   Zhang, Ping ^a   Wang, Rui Yan ^a   Guo, Jian You ^c  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF PSYCHOLOGY   (China)

Author keywords

Allergic contact dermatitis; Aloperine; Interleukin 1 ; Interleukin 6; Tumor necrosis factor alpha

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ALKALOID; ALOPERINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MOMETASONE FUROATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ERYTHEMA; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN BIOPSY; SKIN SWELLING; UPREGULATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DINITROFLUOROBENZENE; EAR; ERYTHEMA; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, INBRED BALB C; PIPERIDINES; RNA, MESSENGER;

EID: 74249093370     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.12.007     Document Type: Article

References (40)

1. Ade N., Antonios D., Kerdine-Romer S., Boisleve F., Rousset F., and Pallardy M. NF-kappaB plays a major role in the maturation of human dendritic cells induced by NiSO(4) but not by DNCB. Toxicol Sci. 99 (2007) 488-501
2. Ade N., Leon F., Pallardy M., Peiffer J.L., Kerdine-Romer S., Tissier M.H., Bonnet P.A., Fabre I., and Ourlin J.C. HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. Toxicol Sci. 107 (2009) 451-460
3. Atarashi K., Kabashima K., Akiyama K., and Tokura Y. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice. Br. J. Dermatol. 159 (2008) 306-313
4. Bhol K.C., and Schechter P.J. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br. J. Dermatol. 152 (2005) 1235-1242
5. Blauvelt A., Hwang S.T., and Udey M.C. 11. Allergic and immunologic diseases of the skin. J. Allergy Clin. Immunol. 111 (2003) S560-S570
6. Bonneville M., Chavagnac C., Vocanson M., Rozieres A., Benetiere J., Pernet I., Denis A., Nicolas J.F., and Hennino A. Skin contact irritation conditions the development and severity of allergic contact dermatitis. J. Invest. Dermatol. 127 (2007) 1430-1435
7. Cruz M.T., Goncalo M., Figueiredo A., Carvalho A.P., Duarte C.B., and Lopes M.C. Contact sensitizer nickel sulfate activates the transcription factors NF-kB and AP-1 and increases the expression of nitric oxide synthase in a skin dendritic cell line. Exp. Dermatol. 13 (2004) 18-26
8. Cruz R., Quintana-Hau J.D., Gonzalez J.R., Tornero-Montano R., Baiza-Duran L.M., and Vega L. Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation. Br. J. Ophthalmol. 92 (2008) 120-125
9. De Vry C.G., Valdez M., Lazarov M., Muhr E., Buelow R., Fong T., and Iyer S. Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model. J. Invest. Dermatol. 125 (2005) 473-481
10. Enk A.H. Allergic contact dermatitis: understanding the immune response and potential for targeted therapy using cytokines. Mol. Med. Today 3 (1997) 423-428
11. Enk A.H., and Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1398-1402
12. Fisher D.A. Adverse effects of topical corticosteroid use. West. J. Med. 162 (1995) 123-126
13. Gober M.D., and Gaspari A.A. Allergic contact dermatitis. Curr. Dir. Autoimmun. 10 (2008) 1-26
14. Griffiths C.E., Dearman R.J., Cumberbatch M., and Kimber I. Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine 32 (2005) 67-70
15. Groves R.W., Allen M.H., Ross E.L., Barker J.N., and MacDonald D.M. Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132 (1995) 345-352
16. He D., Wu L., Kim H.K., Li H., Elmets C.A., and Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 177 (2006) 6852-6858
17. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem. J. 265 (1990) 621-636
18. Inagaki N., Shiraishi N., Igeta K., Itoh T., Chikumoto T., Nagao M., Kim J.F., and Nagai H. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur. J. Pharmacol. 546 (2006) 189-196
19. Ingber A. What's new in contact dermatitis: allergy to topical steroids in Israeli patients with contact dermatitis. Isr. Med. Assoc. J. 4 (2002) 867
20. Johansson S.G., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F., Motala C., Ortega Martell J.A., Platts-Mills T.A., Ring J., Thien F., Van Cauwenberge P., and Williams H.C. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy. Clin. Immunol. 113 (2004) 832-836
21. Kimber I., Cumberbatch M., Humphreys M., and Hopkins S.J. Contact hypersensitivity induces plasma interleukin 6. Int. Arch. Allergy Appl. Immunol. 92 (1990) 97-99
22. Kock A., Schwarz T., Kirnbauer R., Urbanski A., Perry P., Ansel J.C., and Luger T.A. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172 (1990) 1609-1614
23. Koeper L.M., Schulz A., Ahr H.J., and Vohr H.W. In vitro differentiation of skin sensitizers by cell signaling pathways. Toxicology 242 (2007) 144-152
24. Kondo S., Pastore S., Fujisawa H., Shivji G.M., McKenzie R.C., Dinarello C.A., and Sauder D.N. Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J. Invest. Dermatol. 105 (1995) 334-338
25. Kondo S., and Sauder D.N. Epidermal cytokines in allergic contact dermatitis. J. Am. Acad. Dermatol. 33 (1995) 786-800
26. Larrick J.W., Morhenn V., Chiang Y.L., and Shi T. Activated Langerhans cells release tumor necrosis factor. J. Leukoc. Biol. 45 (1989) 429-433
27. Larsen J.M., Bonefeld C.M., Poulsen S.S., Geisler C., and Skov L. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J. Allergy Clin. Immunol. 123 (2009) 486-492
28. Letko E., Bhol K., Pinar V., Foster C.S., and Ahmed A.R. Tacrolimus (FK 506). Ann. Allergy Asthma Immunol. 83 (1999) 179-189 quiz 189-190
29. Olmos A., Giner R.M., Recio M.C., Rios J.L., Cerda-Nicolas J.M., and Manez S. Effects of plant alkylphenols on cytokine production, tyrosine nitration and inflammatory damage in the efferent phase of contact hypersensitivity. Br. J. Pharmacol. 152 (2007) 366-373
30. Oxholm A., Oxholm P., Avnstorp C., and Bendtzen K. Keratinocyte-expression of interleukin-6 but not of tumour necrosis factor-alpha is increased in the allergic and the irritant patch test reaction. Acta Derm. Venereol. 71 (1991) 93-98
31. Piguet P.F., Grau G.E., Hauser C., and Vassalli P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J. Exp. Med. 173 (1991) 673-679
32. Qavi H.B., Wyde P.R., and Khan M.A. In vitro inhibition of HHV-6 replication by sophocarpines. Phytother. Res. 16 (2002) 154-156
33. Reitamo S., Remitz A., Kyllonen H., and Saarikko J. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. Am. J. Clin. Dermatol. 3 (2002) 381-388
34. Schnuch A., Uter W., Geier J., and Gefeller O. Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug-utilization research (CE-DUR) approach. Contact Dermatitis 47 (2002) 32-39
35. Trompezinski S., Migdal C., Tailhardat M., Le Varlet B., Courtellemont P., Haftek M., and Serres M. Characterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways. Toxicol. Appl. Pharmacol. 230 (2008) 397-406
36. Watanabe H., Gaide O., Petrilli V., Martinon F., Contassot E., Roques S., Kummer J.A., Tschopp J., and French L.E. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127 (2007) 1956-1963
37. Wolff K., and Stuetz A. Pimecrolimus for the treatment of inflammatory skin disease. Expert Opin. Pharmacother. 5 (2004) 643-655
38. Worm M. Novel therapies for atopic eczema. Curr. Opin. Investig. Drugs 3 (2002) 1596-1603
39. Yamashita H., Tasaki D., Makino T., Matsuoka K., Nose M., Inagaki N., and Mizukami H. The role of IgE and repeated challenge in the induction of persistent increases in scratching behavior in a mouse model of allergic dermatitis. Eur. J. Pharmacol. 605 (2009) 153-157
40. Zhou C.C., Gao H.B., Sun X.B., Shi H.B., Liu W., Yuan H.N., and Wang Z.X. Anti-inflammatory and anti-allergic action of aloperine. Zhongguo Yao Li Xue Bao 10 (1989) 360-365